Company Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-05-23 am EDT			5-day change	1st Jan Change
442.95 ^DKK	-0.75%		+3.84%	-29.04%

May. 23	The EU's top exports, most vulnerable to Trump's new tariffs	RE
May. 23	Americans scramble as weight-loss drug discounts fall short, copies face crackdown	RE

Business description: Novo Nordisk A/S

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- diabetes and obesity treatment products (93.6%);

- rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Number of employees: 77,406

Sales by Activity: Novo Nordisk A/S

Fiscal Period: December	2020	2021	2022	2023	2024
Diabetes and Obesity Care	108B	122B	156B	215B	272B
Rare Disease	18.93B	19.2B	20.54B	17.16B	18.64B

See all business segments

Geographical breakdown of sales: Novo Nordisk A/S

Fiscal Period: December	2020	2021	2022	2023	2024
United States of America (USA)	57.82B	63.01B	84.66B	128B	167B
EMEA	34.3B	37.71B	44.24B	50.87B	60.4B
Rest of the World	17.45B	19.81B	25.4B	28.08B	33.33B
Region China	14.08B	16.02B	16.21B	16.69B	18.5B
North America (Excl. US)	3.29B	4.25B	6.45B	9.1B	10.77B

See all geographic segments

Executive Committee: Novo Nordisk A/S

Manager	Title	Age	Since
Lars Fruergaard Jorgensen CEO	Chief Executive Officer	59	2016-12-31
Karsten Munk Knudsen DFI	Director of Finance/CFO	54	2018-02-14
Marcus Schindler CTO	Chief Tech/Sci/R&D Officer	58	2021-02-28
Stephen Gough CTO	Chief Tech/Sci/R&D Officer	-	2015-09-30
Maziar Mike Doustdar COO	Chief Operating Officer	55	2016-08-31

See NOVO NORDISK A/S governance

Composition of the Board of Directors: Novo Nordisk A/S

Director	Title	Age	Since
Sylvie Grégoire BRD	Director/Board Member	64	2015-03-18
Kasim Kutay BRD	Director/Board Member	60	2017-03-22
Helge Lund CHM	Chairman	62	2018-03-21
Mette Bøjer Jensen BRD	Director/Board Member	50	2018-03-21
Thomas Rantzau BRD	Director/Board Member	53	2018-03-21
Andreas Fibig BRD	Director/Board Member	63	2018-02-28
Martin MacKay BRD	Director/Board Member	68	2018-02-28
Laurence Debroux BRD	Director/Board Member	55	2019-03-20
Henrik Poulsen BRD	Director/Board Member	58	2021-03-24
Elisabeth Christensen BRD	Director/Board Member	60	2022-03-23

Composition of the Board of Directors

Shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	11 767 M kr
NOVO NORDISK A/S 0.7654 %	25,947,151	0.7654 %	1 720 M kr
State Street Global Advisors Ltd. 0.2048 %	6,942,056	0.2048 %	460 M kr
Sjunde AP-fonden 0.1328 %	4,502,464	0.1328 %	298 M kr
Amundi Asset Management SASU (Investment Management) 0.1268 %	4,298,785	0.1268 %	285 M kr

Name	Equities	%	Valuation
Caixa DTVM SA 0.001423 %	385,880	0.001423 %	3 M kr
Western Asset Management Company DTVM Ltda. 0.001266 %	343,321	0.001266 %	3 M kr
Morgan Stanley Administradora de Carteiras SA 0 %	100	0 %	831 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	71 233 M kr
ANIMA Sgr SpA 0.026 %	279,050	0.026 %	18 M kr
Russell Investments Ltd. 0.002027 %	21,783	0.002027 %	1 M kr

Name	Equities	%	Valuation
Jennison Associates LLC 0.5552 %	18,822,002	0.5552 %	1 251 M kr
Merrill Lynch International 0.4363 %	14,792,624	0.4363 %	983 M kr
Loomis, Sayles & Co. LP 0.3654 %	12,388,242	0.3654 %	823 M kr
Eaton Vance Management 0.3634 %	12,319,787	0.3634 %	819 M kr
Fisher Asset Management LLC 0.3502 %	11,871,236	0.3502 %	789 M kr

List of NOVO NORDISK A/S shareholders

Holdings: Novo Nordisk A/S

Name	Equities	%	Valuation
NOVO NORDISK A/S 0.77%	25,947,151	0.77%	1,719,547,795 $
NNIT A/S 17.5%	4,375,000	17.5%	48,311,638 $
INNATE PHARMA 11.71%	9,817,546	11.71%	21,583,580 $

Company details: Novo Nordisk A/S

Novo Nordisk A/S

Novo Allé 1

2880, Bagsværd

+45 44 44 88 88

http://www.novonordisk.com

Group companies: Novo Nordisk A/S

Name	Category and Sector
Novo Nordisk Service Centre (India) Pvt Ltd. Novo Nordisk Service Centre (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Novo Nordisk Service Centre (India) Pvt Ltd. is a company based in Bangalore, India. Novo Nordisk Service Centre (India) Pvt Ltd. was founded in 2011.	Pharmaceuticals: Major
Novo Nordisk India Pvt Ltd. Novo Nordisk India Pvt Ltd. Medical/Nursing ServicesHealth Services Part of Novo Nordisk A/S, Novo Nordisk India Pvt Ltd. is a leading healthcare company founded in 1923 and headquartered in Denmark. The company is based in Bengaluru, India. Novo Nordisk's purpose is to drive change to defeat diabetes and other serious chronic diseases.	Medical/Nursing Services
Velfærdsfonden for Novo Nordisk A/S	Investment Trusts/Mutual Funds
NNE A/S NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark.	Engineering & Construction
World Diabetes Foundation	Investment Trusts/Mutual Funds

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
NOVO NORDISK A/S	-0.75%	+3.84%	-52.75%	+17.84%	299B
ELI LILLY AND COMPANY	-0.21%	-5.77%	-11.72%	+135.86%	641B
JOHNSON & JOHNSON	+0.22%	+1.06%	+2.16%	-14.77%	368B
ABBVIE INC.	+0.39%	-0.41%	+15.80%	+23.80%	324B
ROCHE HOLDING AG	+0.27%	+0.08%	+11.98%	-19.91%	254B
NOVARTIS AG	-0.26%	+1.41%	-0.01%	+5.79%	221B
ASTRAZENECA PLC	+0.60%	+1.03%	-15.87%	-1.55%	218B
MERCK & CO., INC.	-0.33%	+2.00%	-40.82%	-17.32%	195B
AMGEN INC.	-0.09%	-0.28%	-11.37%	+9.08%	146B
GILEAD SCIENCES, INC.	+0.59%	+4.75%	+62.26%	+68.66%	134B
Average	+0.04%	+0.77%	-4.03%	+20.75%	279.87B
Weighted average by Cap.	-0.00%	-0.27%	-6.82%	+34.90%